The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Wealth Within’s Dale Gillham and Filip Tortevski discuss the best performers over the past week and name Rio Tinto (ASX:RIO) their ‘Not Hot’ stock.

Dale Gillham and Filip Tortevski question how the stock will trade into the near future.

On the other hand, their ‘Hot Stock’ tip is plumbing and heating solutions company, Reliance Worldwide Corporation (ASX:RWC).

It’s a $3.8 billion market cap company. Reliance traded up half a per cent today to around $4.95.

Their ‘Proceed with Caution’ stock is $1.4 billion market cap accommodation software provider SiteMinder (ASX:SDR) which has been trading at $5.25.

Dale Gillham is Chief Analyst at Wealth Within and international bestselling author of How to Beat the Managed Funds by 20%. He is also the author of Accelerate Your Wealth—It’s Your Money, Your Choice, which is available in bookstores and online at www.wealthwithin.com.au

Disclaimers: While Wealth Within holds an Australian Financial Services License (AFSL:226347) the information featured in this program is general in nature and therefore should not be relied upon. Before making any investment decisions, you should consult a licensed professional who can advise whether your investment decisions are appropriate for you.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

More From The Market Online
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham: Is oil preparing for another US$100 breakout?

Want to make $100,000 in just seven days? It might sound impossible, but that’s exactly the kind of opportunity the oil market delivered
The Market Online Video

Syntara shows encouraging first signals it can impact the path to Parkinson’s

Syntara (ASX:SNT) has reported encouraging interim results from its Phase 2 study of SNT-4728, providing the first clinical evidence
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham: Has hype replaced value in modern financial markets?

Here’s an uncomfortable question: are markets still rewarding good investing, or simply rewarding whoever can influence the crowd first? Over the past few
The Market Online Video

Wealth Within: Is gold’s sell-off ending? 3 top ASX stock picks

Gold has fallen almost 30% from its CY26 high, but could this be setting up one of the biggest opportunities in the market